IAMGOLD (TSX:IMG,NYSE:IAG) is tightening its grip on one of Québec’s most promising gold districts with back-to-back acquisitions aimed at consolidating control over a vast...
Astron (ASX:ATR) said on Monday (October 20) that Australia has granted major project status to the Donald rare earths and mineral sands project, its...
Chris Vermeulen, chief market strategist at TheTechnicalTraders.com, weighs in on gold’s record-setting price run and what could be next for the metal. Vermeulen also...
Investor Insight Spartan Metals offers a compelling investment opportunity in the US critical minerals sector through its high-grade, 100-percent-owned Eagle tungsten-silver-rubidium project in Nevada....
Spartan Metals (TSXV:W) is a US-focused explorer advancing its high-grade tungsten and rubidium Eagle Project in Nevada. The company is unlocking critical minerals essential...
Basin Energy (BSN:AU) has announced Significant Mineralisation Confirmed In Sweden Download the PDF here. This post appeared first on investingnews.com
Torchlight Innovations Inc. (TSXV: TLX.P) (‘Torchlight’ or ‘the Company’), doing business as RZOLV Technologies, is pleased to announce positive preliminary results from its metallurgical...
Australian Prime Minister Anthony Albanese and US President Donald Trump signed a rare earths deal during their meeting at the White House on Monday...
The cleantech sector experienced a dynamic third quarter, with predictions of volatility coming to fruition. While global investment in renewable energy is strong, notable...
Gold Fields (NYSE:GFI) has completed its AU$3.7 billion purchase of Gold Road Resources. Gold Road rejected Gold Fields’ first acquisition proposal in March, saying...
China has accused the US of “seriously distorting and exaggerating” Beijing’s newly expanded rare earths export controls, but signaled a willingness to hold talks...
Vince Lanci of Echobay Partners explains what’s driving silver’s record-setting price run. According to Lanci, who is also a professor at the University of...
MAVERIC Phase III pivotal trial of orphan drug candidate CardiolRx in recurrent pericarditis is fully funded through to a planned New Drug Application submission...